Gastroenterology Market Size, Share, Growth and Industry Analysis By Type (Gastrointestinal Tract Diseases, And, Gastrointestinal Organs Diseases) By Application (Hospitals, Clinics, Drug Store/Pharmacies, And, Others) Regional Forecast To 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

GASTROENTEROLOGY MARKET OVERVIEW

The global Gastroenterology Market is set to rise from USD 64.35 Billion in 2025 to USD 69.07 Billion in 2026, on track to hit USD 130.65 Billion by 2035, growing at a CAGR of 7.34% between 2025 and 2035.

As a medical field Gastroenterology studies all disorders related to the digestive system. Gastroenterology diagnoses and treats medical disorders that affect the esophagus together with stomach and intestines and the liver and pancreas and gallbladder. Gastroenterologists both detect and provide treatments for medical conditions that include acid reflux along with ulcers as well as irritable bowel syndrome (IBS), Crohn's disease and liver diseases. The medical experts use both endoscopy and colonoscopy procedures to check the digestive tract. Proper gut health depends on carefully balanced diet together with water consumption and the addition of probiotics to support our general health. Detecting gastrointestinal illnesses at an early stage allows better treatment results and better living quality for patients.

KEY FINDINGS

COVID-19 IMPACT

Elevated Occurrences of Gastrointestinal Symptoms during Pandemic Increased Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

Gastroenterology witnessed significant transformations due to COVID-19 because the virus raised the frequency of gastrointestinal symptoms that comprised diarrhea accompanied by nausea and decreased appetite levels. When the virus entered the body it altered the gut micro biome while triggering inflammation development. The pandemic resulted in delayed gastroenterology procedures so patients faced delayed colorectal cancer diagnoses. IBD patients alongside those who have other digestive diseases struggled to get proper healthcare treatment.

LATEST TRENDS

Artificial Intelligence (AI) Which Enhances the Detection of Gastrointestinal Lesions to Accelerate Market Growth

New endoscopic diagnostics employ artificial intelligence (AI) to boost the discovery of gastrointestinal lesions because of modern gastroenterology developments. The medical field now adopts video capsule endoscopy as a less painful method to explore a patient's total digestive tract without surgery. Modern pharmacological weight loss aids entered the market to help patients manage their obesity. New treatments for alcohol-related liver disease are actively developed by investigators to improve patient success results. Telemedicine remote care services now serve as a common practice to deliver home-based medical services for chronic gastrointestinal condition patients. The gastroenterology market experiences expansion because of these market changes. These trends are driving the gastroenterology market growth.

• According to the World Health Organization (WHO), global gastrointestinal disorder screenings have increased by 34% between 2019 and 2024, driven by national preventive health programs. The U.S. Centers for Disease Control and Prevention (CDC) reported that 62% of adults aged over 50 underwent at least one GI screening in 2023, a rise of 14% compared to 2020, reflecting early diagnosis initiatives.

• As per the U.S. Food and Drug Administration (FDA), approvals for minimally invasive endoscopy devices rose by 29% from 2020 to 2024, reflecting the shift toward faster recovery and reduced hospital stay procedures. Additionally, the European Society of Gastrointestinal Endoscopy (ESGE) stated that 48% of gastroenterology centers in Europe have transitioned to advanced endoscopic visualization systems by 2023.
•   
•   
  

  Download Free Sample to learn more about this report

    

GASTROENTEROLOGY MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into gastrointestinal tract diseases, and, gastrointestinal organs diseases

• Gastrointestinal Tract Diseases: Gastrointestinal Tract Diseases affect every section from the esophagus until the rectum including the stomach along with the intestines. The digestive tract contains four major conditions: acid reflux, irritable bowel syndrome (IBS), Crohn’s disease and colorectal cancer that modify digestion functions and complete wellness.

• Gastrointestinal Organ Diseases: These disorders affect individual parts of the digestive system which consist of liver pancrease and gallbladder among others. The disorders fatty liver disease and pancreatitis together with gallstones create digestive issues and metabolic problems that diminish nutrient absorption so patients need medical supervision for management.

By Application

Based on Type, the global market can be categorized into hospitals, clinics, drug store/pharmacies, and, others

• Hospitals: Health departments in hospitals offer complete medical treatment options spanning from urgent care to surgical procedures together with specialized medical interventions. The healthcare facilities combine top-of-the-line equipment with knowledgeable medical staff to deal with challenging health issues.

• Clinics: The medical facilities of clinics serve their patients through their outpatient services which include routine check-ups together with minor procedural treatments as well as specialized medical care. The healthcare facilities offer patients a combination of lower costs and easier access for their routine consultation needs.

• Drug Stores/Pharmacies: Pharmacies supply prescription and over-the-counter medications, along with health essentials. The guidance provided by pharmacists includes mentoring customers on how to use their medications and what side effects may occur.

• Others: Other healthcare establishments in this category include diagnostic centers in addition to rehabilitation facilities as well as home healthcare services. These provide essential support for disease prevention, recovery, and long-term patient care

MARKET DYNAMICS

Driving Factors

Technological Advancements in Gastroenterology to Amplify Market Growth

Medical technology development serves as a substantial force for gastroenterology because it enhances diagnostic precision and treatment success. The use of AI in endoscopic procedures facilitates early illness identification in the gastrointestinal tract thus reducing mortality statistics. Robot-assisted surgeries employed together with capsule endoscopic procedures present safer treatment possibilities that enhance surgical efficiency compared to typical traditional surgical practices. Modern medical research has combined precision-based medicine techniques with targeted therapeutic treatments to improve patient responses in Crohn’s disease and colorectal cancer patients. All of the above-mentioned factors are driving the gastroenterology market share.

• According to the National Institutes of Health (NIH), around 60 to 70 million Americans are affected by digestive diseases annually, accounting for approximately 22% of total hospital admissions in the United States. The World Gastroenterology Organisation (WGO) also reported a 31% global increase in inflammatory bowel disease (IBD) cases since 2018, intensifying the demand for gastroenterology services and technologies.

• The U.S. Department of Health and Human Services (HHS) reported a 45% increase in federal funding for endoscopic and diagnostic imaging research between 2020 and 2024. Similarly, according to the European Commission’s Health Programme, €220 million (equivalent to 17% of its research budget) was allocated in 2023 to develop innovative GI diagnostic platforms.

Rising Prevalence of Gastrointestinal Disorders to Propel Market Growth

Medical demands for sophisticated gastroenterology treatments rise because digestive disorders affect an increasing number of individuals worldwide. The prevalence of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) plus acid reflux is growing because people change their lifestyle and eat poorly and experience stress. Liver disease prevalence exhibits an upward trend while non-alcoholic fatty liver disease (NAFLD) joins NAFLD as one of the growing disease burdens thus emphasizing the need for hydrogel-containing treatments. Early diagnosis understanding together with spreading digestive health knowledge has resulted in increased utilization of endoscopic examinations as well as preventive medical practices. The above mentioned factors are contributing to the rapid growth and development of the market.

Restraining Factor

Expensive Nature of Diagnostic Equipment That Includes Endoscopes And Robotic-Assisted Tools to Decrease Market Growth

Several challenges limit the growth and accessibility of gastroenterology services. The expensive nature of diagnostic equipment that includes endoscopes and robotic-assisted tools restricts their accessibility due to high costs for patients. Timely medical diagnosis and treatment suffer from inadequate trainings of gastroenterologists together with limited specialized healthcare facilities. Late-stage disease detection occurs because patients delay screenings from not wanting it and having insufficient awareness. Innovative treatments are restricted by regulatory barriers as well as insurance coverage restrictions. Enhancing digestive healthcare requires the elimination of these barriers which will improve patient results. All of these factors are disrupting the market growth and development.

• According to the World Bank Health Expenditure Database, specialized medical equipment costs for gastroenterology have increased by 26% globally from 2019 to 2023. The American Hospital Association (AHA) reports that 43% of small healthcare facilities delay adoption of endoscopy systems due to high maintenance expenses and staff training requirements.

• As per the Association of American Medical Colleges (AAMC), the United States faces a shortage of approximately 1,630 gastroenterologists as of 2024, which represents a 17% gap relative to national demand. The World Health Organization (WHO) estimates that 37% of low- and middle-income countries have inadequate gastroenterology specialist coverage.

Advancements of Telemedicine to Create an Opportunity in the Market

Opportunity

The field of gastroenterology is revolutionizing through artificial intelligence (AI) and precision medicine developments which lead to enhanced early disease recognition and tailored medical approaches. Telemedicine has created opportunities for remote consults which expands healthcare access to patients who need it in areas with limited medical providers. Due to increased understanding of gut health and preventive measures the need for standard screenings like colonoscopy has increased among the population. Because of ongoing research researchers have developed micro-biome-based treatments and minimally invasive therapies that can help patients who suffer from inflammatory bowel disease (IBD) and liver disorders. The field of gastroenterology continues to grow because healthcare infrastructure increases alongside research investments. These factors are creating several opportunities in the market that help propel its rapid development.

• According to the U.S. Centers for Medicare & Medicaid Services (CMS), telehealth consultations for gastroenterology increased by 56% between 2020 and 2024. The Asia Pacific Association of Gastroenterology (APAGE) also observed that 49% of hospitals in the Asia-Pacific region now offer remote consultations for gastrointestinal conditions, creating strong growth potential for digital diagnostic platforms.

• The National Institute for Health and Care Excellence (NICE) in the U.K. reported that artificial intelligence (AI)-assisted colonoscopy procedures improved polyp detection accuracy by 20% compared to traditional methods. Meanwhile, the Japan Gastroenterological Endoscopy Society (JGES) stated that 44% of new endoscopy systems installed in 2023 were AI-enabled, showing increasing investment in machine-learning-assisted diagnostics.

Expensive Nature of Sophisticated Diagnostic Instruments to Create Challenge in the Market

Challenge

Various factors continue to affect the delivery of gastroenterology services even though improvements have occurred. Most patients face limitations in treatment access due to the expensive nature of sophisticated diagnostic instruments and therapeutic interventions. Stay durations become longer for patients due to limited availability of gastroenterologists who have undergone proper training in this field. Gastrointestinal disease treatment becomes more complex when patients experience delayed diagnosis because of insufficient awareness about screening and delayed testing. The process of obtaining regulatory approval for new therapies extends for a prolonged period which impedes innovation. Chronic digestive conditions involving irritable bowel syndrome (IBS) and Crohn’s disease prove difficult to manage because of dissimilar treatment results in patients.

• According to the U.S. Food and Drug Administration (FDA), only 68% of new endoscopic devices submitted between 2021 and 2023 were approved on the first review cycle, due to complex safety verification requirements. Similarly, the European Medicines Agency (EMA) reported that 21% of GI diagnostic tools face extended approval delays exceeding 12 months.

• The World Health Organization (WHO) observed a 9.5% rise in post-endoscopy infection rates in 2023 compared to 2020, largely due to inadequate disinfection protocols in smaller clinical settings. The U.S. Centers for Disease Control and Prevention (CDC) reported that 14% of hospital-acquired infections in the U.S. originate from improperly sterilized endoscopic instruments.

•   
•   
  Download Free Sample to learn more about this report

    

GASTROENTEROLOGY MARKET REGIONAL INSIGHTS

• North America

Gastroenterology progress in North America operates from the combination of extensive healthcare spending and superior technological capabilities with laboratory research support. The area shows elevated rates of gastrointestinal illnesses which include both colorectal cancer together with inflammatory bowel disease (IBD) because this results in growing need for early detection solutions as well as modern therapeutic strategies. AI-assisted diagnostics work together with minimally invasive procedures to generate enhanced patient healthcare quality. The U.S. together with Canada controlling well-developed healthcare systems maintains efficient care delivery while patients gain better understanding about digestive health. The high expenses associated with treatments as well as complex insurance regulations persist as major barriers for universal healthcare accessibility.

• Europe

The European gastroenterology sector expands because digestion diseases rise and government healthcare programs support treatment and the population ages. Barriers to gastroenterological care in Europe exist due to the leading positions of Germany along with the U.K. and France within hi-tech endoscopy measurements and microbe laboratory research. The development of innovative therapies receives support from strong regulatory frameworks at the same time as broader preventive screenings enable early diagnosis of diseases. Healthcare accessibility differs greatly across Western and Eastern European territories which creates substantial barriers to care. Medical screenings in public healthcare organizations face lengthy waits for specialist appointments which impact both diagnosis timing and treatment commencement.

• Asia

The Asia Pacific shows an escalating trend in gastroenterology partly because of rising digestive conditions in addition to modified dietary patterns and improved healthcare facilities. The nations China and India and Japan deploy their funding resources toward acquiring innovative medical diagnosis instruments as well as performing minimally invasive medical procedures. The increasing knowledge about gut health combined with population growth among middle-class communities drives people to seek screening services and improved medical solutions. The rural regions face several hurdles including inadequate specialist healthcare professionals along with unforeseen medical standards and cost barriers. The regional improvement of gastroenterology care requires government-sponsored initiatives as well as investments from private corporations.

KEY INDUSTRY PLAYERS

Leading Players adopt Acquisition Strategies to Stay Competitive

Several players in the market are using acquisition strategies to build their business portfolio and strengthen their market position. In addition, partnerships and collaborations are among the common strategies adopted by companies. Key market players are making R&D investments to bring advanced technologies and solutions to the market. Several companies in the market are focusing on strategic mergers and acquisitions to expand their product offerings and enhance their market presence. Collaborations with construction and technology firms are becoming more prevalent, allowing for integrated solutions that meet the evolving demands of clients. Market leaders are investing heavily in research and development to innovate new materials, improve system durability, and enhance performance. These initiatives are aimed at offering more sustainable, cost-effective, and customizable flooring options, thereby solidifying their competitive advantage in the rapidly evolving market landscape.

• Johnson & Johnson: According to the U.S. Food and Drug Administration (FDA), Johnson & Johnson’s subsidiary Ethicon holds regulatory clearance for over 120 gastroenterology-related surgical and diagnostic products. The company’s devices are utilized in approximately 38% of GI minimally invasive surgeries across major U.S. hospitals.

• Physicians Endoscopy: The American Society for Gastrointestinal Endoscopy (ASGE) reported that Physicians Endoscopy manages partnerships with over 60 independent endoscopy centers across the U.S., representing approximately 7% of all outpatient GI procedures nationally.

List of Top Gastroenterology Companies

• Johnson & Johnson (U.S.)
• Physicians Endoscopy (U.S.)
• Fujifilm Medical Systems USA (U.S.)
• EndoGastric Solutions (U.S.)
• Allergan Pharmaceuticals (Ireland)
• US Endoscopy Group (U.S.)
• Olympus Corp. of the Americas (U.S.)
• Motus GI (U.S.)
• Shaili Endoscopy (India)
• Modernizing Medicine Co. (U.S.)
• Salix Pharmaceuticals (U.S.)
• Cogentix Medical (U.S.)
• Boston Scientific (U.S.)
• Takeda Pharmaceuticals USA (Japan)
• Synergy Pharmaceuticals (U.S.)
• Evoke Pharma (U.S.)
• EndoChoice (U.S.)
• Exact Sciences Corp. (U.S.)
• Interscope (U.S.)
• Pentax Medical USA (Japan)

INDUSTRIAL DEVELOPMENT

May 2024: The GI Genius™ system obtained a major update with the ColonPRO™ software release by Medtronic in 2024. The most recent update of this software includes a more advanced algorithm that utilizes a double-sized dataset to achieve 9% better performance in detecting false positives. Procedural highlights are among new features provided by the system which strives to simplify physician operations together with reducing documentation obligations. The updated software provides better opportunities for colorectal abnormality detection which enhances gastroenterology patient experiences

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.